1. Protective effects of valproic acid on 6-hydroxydopamine-induced neuroinjury
- Author
-
Wen Shin Chang, Jai Sing Yang, Chia-Wen Tsai, Fuu Jen Tsai, Da Tian Bau, Pei Chen Hsu, Chien Chih Yu, Shih Wei Hsu, Kai Yuan Chen, and Yun Chi Wang
- Subjects
Cell Survival ,Health, Toxicology and Mutagenesis ,Dopamine ,Apoptosis ,010501 environmental sciences ,Management, Monitoring, Policy and Law ,Pharmacology ,Toxicology ,medicine.disease_cause ,01 natural sciences ,Neuroprotection ,03 medical and health sciences ,Mice ,0302 clinical medicine ,Dopaminergic Cell ,Cell Line, Tumor ,medicine ,Animals ,Humans ,Oxidopamine ,Caspase ,0105 earth and related environmental sciences ,Neurons ,Hydroxydopamine ,biology ,Cell Death ,Chemistry ,Caspase 3 ,Valproic Acid ,Dopaminergic ,Neurotoxicity ,General Medicine ,medicine.disease ,Oxidative Stress ,Neuroprotective Agents ,nervous system ,030220 oncology & carcinogenesis ,biology.protein ,lipids (amino acids, peptides, and proteins) ,Neurotoxicity Syndromes ,Reactive Oxygen Species ,Oxidative stress - Abstract
Oxidative stress may play critically important roles in the etiology of Parkinson's disease (PD). 6-Hydroxydopamine (6-OHDA) is a physiological neurotoxin reported to induce oxidative-induced apoptosis of dopaminergic neurons in PD mice models. Valproic acid (VPA), a clinical mood stabilizer, is a HDAC inhibitor with neuroprotective capacities. In the study, we aim at examining the feasibility of VPA as a protector for dopaminergic neurons against damage from 6-OHDA, and the intracellular mechanisms. The 6-OHDA-induced neurotoxicity to the human dopaminergic cell line SH-SY5Y was applied for examining VPA protective effects. Pretreatment with VPA was able to improve cell viability and reduce 6-OHDA-induced reactive oxygen species. Furthermore, a significant suppression of apoptotic caspases including cleaved caspase-3, caspase-7, and caspase-9 was observed. The results also revealed VPA decreased the 6-OHDA-induced Bax/Bcl2 ratio, as measured at protein level. These novel findings indicate that VPA may be capable of protecting the SH-SY5Y dopaminergic neuronal cells from 6-OHDA-induced toxicity via the deceasing of apoptotic caspases (cleaved caspase-3, caspase-7, and caspase-9) and reducing of the Bax/Bcl2 ratio. Very possibly, VPA could serve as not only a mood stabilizer but also a potential antidote for PD prevention.
- Published
- 2019